文献速递核素与放射性配体治疗放射性药物与辐射防护

放射性药物治疗中健康组织临床前体内剂量学:GATE中生理逼真小鼠眼模型的实现

Preclinical in vivo dosimetry of healthy tissues in radiopharmaceutical therapy: implementation of a physiologically realistic mouse eye model in GATE.
PubMed 文献 · EJNMMI Res · 2026-04-04

本研究构建了首个基于高分辨率MRI与SIMS成像的体素化小鼠眼模型,用于靶向放射性核素治疗中的微剂量学评估。以实验性放射性药物[131I]ICF01012为例,通过离体伽马计数获取眼内生物分布,并利用GATE蒙特卡罗模拟计算眼内结构S值。结果显示富黑色素区域碘-127信号增高,视网膜色素上皮剂量最高(24.14 Gy.MBq⁻¹),视网膜吸收剂量为6.91 Gy.MBq⁻¹。

要点

  • 构建了首个解剖精确的体素化小鼠眼模型用于微剂量学评估。
  • 视网膜色素上皮吸收剂量最高,为24.14 Gy.MBq⁻¹。
  • 放射性示踪剂在注射后21天仍持续滞留于眼组织。

核心结论

  • 本研究提出了新型小鼠眼剂量学模型,为富黑色素组织暴露于碘-131辐射提供了关键见解。

研究设计与样本

  • 利用C57Bl/6J小鼠的高分辨率MRI和SIMS成像数据构建体素化小鼠眼模型,通过离体伽马计数评估眼内放射性生物分布,并采用GATE蒙特卡罗模拟计算眼内结构S值。

主要发现

  • SIMS成像显示富黑色素区域(尤其是视网膜色素上皮和脉络膜)碘-127信号增高。
  • 获得了眼内所有相关源区和靶区的S值。
  • 放射性示踪剂在注射后21天仍持续滞留。
  • 视网膜色素上皮吸收剂量最高,为24.14 Gy.MBq⁻¹,对应视网膜估计吸收剂量为6.91 Gy.MBq⁻¹。

临床怎么用

  • 该模型可用于临床前研究中优化治疗效果并最小化毒性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Targeted radionuclide therapy is a rapidly growing treatment modality that has shown great promise in managing metastatic cancers. However, the affinity of certain radiopharmaceuticals for off-target healthy tissues necessitates accurate dosimetric evaluations. This is especially the case for [131I]ICF01012, an experimental radiopharmaceutical used for advanced melanoma targeted radionuclide therapy, which targets melanin in pigmented tumors and metastases but also in melanized healthy tissues, including sensitive structures such as the retinal pigment epithelium. This study aimed to create the first anatomically precise, voxel-based mouse eye model to facilitate microdosimetric evaluations in the context of targeted radionuclide therapy. A voxelized model of the mouse eye was constructed using high-resolution MRI and SIMS imaging data from C57Bl/6J mice. The biodistribution of radioactivity in the eyes was assessed ex vivo by gamma counting. GATE Monte Carlo simulations were employed to calculate the S-values of the intraocular structures. Particular attention was given to the absorbed dose by the retina considering its proximity to the retinal pigment epithelium, which contains melanin. RESULTS: SIMS imaging revealed an increased iodine-127 signal in melanin-rich regions, particularly the retinal pigment epithelium and choroid. S values were obtained for all relevant source and target regions of the eye. Time-dependent biodistribution analysis of radioactivity revealed persistent retention of the radiotracer up to 21 days after injection. The retinal pigment epithelium received the highest dose, 24.14 Gy.MBq⁻¹, corresponding to an estimated absorbed dose by the retina of 6.91 Gy.MBq⁻¹. CONCLUSION: This work presents a novel dosimetry model for the mouse eye, providing essential insights into the exposure of melanin-rich tissues to iodine-131 radiation. Such models are necessary for optimizing therapeutic efficacy while minimizing toxicity in preclinical studies.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Jouberton E, Sas N, Billoux T, et al. Preclinical in vivo dosimetry of healthy tissues in radiopharmaceutical therapy: implementation of a physiologically realistic mouse eye model in GATE. EJNMMI Res. 2026. PMID: 41934556. doi:10.1186/s13550-026-01423-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。